Connect with us

Business

Strategic expansion, digital & offline pharmacies driving growth: Dr Suneeta Reddy, Apollo Hospitals

Published

on

Strategic expansion, digital & offline pharmacies driving growth: Dr Suneeta Reddy, Apollo Hospitals
Apollo Hospitals posted robust quarterly results, driven by strong revenue growth across its healthcare and pharmacy businesses. The company reported a revenue of ₹6,477 crores, marking a 17% increase, which translated into an EBITDA of ₹965 crores—a 27% improvement. Net profit rose 35% to ₹502 crores, reflecting the impact of higher volumes in high-end specialties and operational efficiency.

Dr Suneeta Reddy, MD of Apollo Hospitals, highlighted the hospital segment’s performance: “Hospital did very well. A growth of 14% in revenues with a revenue of ₹3,183 crores, EBITDA at ₹790 crores representing a 17% increase in EBITDA and profits for the hospital of ₹422 crores representing a 21% improvement in profit.”

Occupancy rates for the quarter stood at 67.1%, slightly below expectations. “There was a 4% improvement in ALOS, which meant that we came down to 3.14 days. If we had been at four days ALOS, we would technically have been at 72% occupancy. So, we have carefully managed to reduce average length of stay to enable patients to really go home faster and to reduce their bills,” said Dr Reddy.

Apollo’s expansion plans remain aggressive. During the quarter, the company opened 100 beds in Pune and 40 beds in Defence Colony. By the first quarter of the next fiscal year, Apollo expects to open 1,035 beds across several new facilities, including Belenus Hospital in Sarjapur (Bangalore), Sonarpur (Kolkata), and Sandhya Elite (Hyderabad), with further expansion planned in Gurgaon.

Advertisement

Regarding profitability, Dr Reddy explained the company’s margin performance: “If you look at healthcare services, we are at a very healthy 24.8%. Apollo Health and Lifestyle is at 10.2%. They have grown their EBITDA margin by 141 basis points. Apollo Healthco is at 4.5%, but that is a different retail business. Offline pharmacies are at 7.8%.”


The pharmacy segment continues to grow strongly, with Healthco adding 185 physical pharmacies this quarter, bringing the total to 7,113—the largest pharmacy network in India. “They have a private label share of 15.53%, which is giving them the margin of 7.8, a very healthy margin, which has improved by 12 basis points. The offline continues to grow with the GMV of ₹525 crores for the quarter, and they have three sources of revenue—insurance, doctor consult, diagnostics, and delivering pharmaceutical products at home—all of them growing at somewhere 23% but growing strongly at 20%,” she added.
The company’s Health and Lifestyle business, despite being loss-making, showed strong growth with a 20% revenue increase and a 39% jump in EBITDA. Dr Reddy expects the segment to turn profitable in the next quarter: “If you look at the different lines of the business, they are all profitable. A little bit of focus on admin costs, etc., they should be profitable, and they are growing the diagnostics scale, which is giving them a healthy 10.8% margin. That margin trajectory will grow.”On the international front, Apollo is focusing on project work and consultancy rather than setting up hospitals overseas. “We have got about ₹20 crores of revenue from the work that we do and project in,” Dr Reddy noted.

Apollo’s capital expenditure plan for expansion includes 1,385 new beds at an estimated cost of ₹2 crores per bed, totaling ₹3,000 crores for the current phase, with another ₹3,000 crores planned for the next phase. Regarding other business verticals, Dr Reddy said: “Healthco is now, it will become a separate company. It is fully capitalised, requires no further capital. Apollo Health and Lifestyle is looking at some restructuring that will bring it capital for growth…Apollo is always there to support them with capital for growth.”

With strong operational performance and strategic expansion plans across hospitals, pharmacies, and lifestyle businesses, Apollo Hospitals continues to reinforce its position as a leader in India’s healthcare sector.

Advertisement
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

US budget deficit tops $1 trillion in first 5 months of fiscal 2026

Published

on

US budget deficit tops $1 trillion in first 5 months of fiscal 2026

The federal budget deficit topped $1 trillion in the first five months of fiscal year 2026, as the U.S. government is on pace to record another massive deficit.

The nonpartisan Congressional Budget Office (CBO) reported that the federal budget deficit was just over $1 trillion through five months of fiscal year 2026, with the size of the deficit down $142 billion or 14% when compared with the same period in fiscal year 2025.

Advertisement

CBO noted that federal spending was just over $3.1 trillion in the first five months of fiscal year 2026, up $64 billion, or 2%, from the same period a year ago. Federal tax revenue collected jumped $206 billion, or 11%, when compared with last year and totaled nearly $2.1 trillion.

The rise in federal tax receipts was attributed to higher collections from individual income taxes and payroll taxes, with CBO noting those accounted for about two-thirds of the increase, while higher tariff rates also increased the amount of import taxes collected.

US DEBT SET TO CRUSH WORLD WAR II RECORD AS ANNUAL DEFICITS EXPLODE TO $3T WITHIN DECADE

US Capitol at sunrise

The federal budget deficit topped $1 trillion in the first five months of fiscal year 2026, down slightly compared with last year. (J. David Ake/Getty Images / Getty Images)

CBO said that from October through February, individual income tax collections were up $99 billion, or 10%, when compared with the same period in the prior fiscal year, while payroll tax collections rose $34 billion, or 5%.

Advertisement

Customs duties, a category which includes tariffs, totaled $144 billion in the first five months of fiscal year 2026 – up $109 billion, or 308%, from the same period in the prior fiscal year. 

Some of those tariffs collected may ultimately be refunded to the businesses and individuals who paid them after the U.S. Supreme Court ruled that the Trump administration’s tariffs imposed under the International Economic Emergency Powers Act (IEEPA) were unconstitutional. 

Tariff refunds would lower federal tax revenue and thereby increase the deficit, and while the Trump administration has moved to implement replacement tariffs, those may face similar legal challenges and collections could face delays.

WHAT ARE THE BIGGEST BUDGET DEFICITS IN US HISTORY?

Advertisement

Corporate income tax collections were down $33 billion, or 23%, in the first five months of the year due to provisions in the 2025 reconciliation bill that increased the tax deductions available to companies making certain eligible investments.

Federal spending increased the most for Social Security and Medicare, the mandatory spending programs that have seen enrollment surge in recent years amid the aging of America’s population.

Spending on Social Security totaled $676 billion in the first five months of fiscal year 2026 – an increase of $48 billion, or 8%, from the same period last year. CBO noted the annual cost-of-living adjustment boosted benefit amounts, while the Social Security Fairness Act’s expansion of benefits eligibility to previously non-covered professions accounted for about $7 billion of the increase.

Medicare spending jumped $34 billion, or 9%, from a year ago to a total of $475 billion in that period, which CBO attributed to higher enrollment and increased payment rates for services.

Advertisement

SOCIAL SECURITY’S MAIN TRUST FUND FACES DEPLETION IN 2032, TRIGGERING BENEFIT CUTS

Another significant mandatory program saw a similar rise in spending as outlays on Medicaid also increased by $22 billion, a rise of 8%, to a total of $285 billion in the five-month period.

Interest expenses on the national debt also saw a notable jump, with net interest costs totaling $433 billion in the first five months of the fiscal year. That’s a jump of $31 billion, or 8%, from the previous year and was due to the larger national debt and higher interest rates.

While spending on the Department of War rose $14 billion, or 4%, and the Department of Veterans Affairs increased $11 billion, or 7%, in the first five months of fiscal year 2026 compared with last year, several agencies saw notable decreases.

Advertisement

Spending by the Environmental Protection Agency (EPA) decreased by $20 billion, or 74%, though that decrease was due to a $20 billion expenditure in November and December 2024 under a clean energy grant program and no comparable outlay was made in 2025.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

A similar dynamic played out with the Department of Homeland Security, which saw spending decline by $12 billion, or 23%, due to a relative decrease in spending on disasters when compared with the prior year despite being partially offset by higher spending on immigration enforcement.

Advertisement
Continue Reading

Business

BlackRock – Diversification Away From ETFs Comes To Bite (NYSE:BLK)

Published

on

BlackRock - Diversification Away From ETFs Comes To Bite (NYSE:BLK)

This article was written by

The Value Investor has a Master of Science with specialization in financial markets and a decade of experience tracking companies via catalytic company events.
As the leader of the investing group Value In Corporate Events they provide members with opportunities to capitalize on IPOs, mergers & acquisitions, earnings reports and changes in corporate capital allocation. Coverage includes 10 major events a month with an eye towards finding the best opportunities. Learn more.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

Zevra Therapeutics, Inc. (ZVRA) Q4 2025 Earnings Call Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Zevra Therapeutics, Inc. (ZVRA) Q4 2025 Earnings Call March 9, 2026 4:30 PM EDT

Company Participants

Nichol Ochsner – Vice President of Investor Relations & Corporate Communications
Neil McFarlane – President, CEO & Director
Joshua Schafer – Chief Commercial Officer
Justin Renz – Chief Financial Officer

Conference Call Participants

Advertisement

Kristen Kluska – Cantor Fitzgerald & Co., Research Division
Jason Butler – Citizens JMP Securities, LLC, Research Division
Eddie Hickman – Guggenheim Securities, LLC, Research Division
Sumant Kulkarni – Canaccord Genuity Corp., Research Division
Brandon Folkes – H.C. Wainwright & Co, LLC, Research Division
Lachlan Hanbury-Brown – William Blair & Company L.L.C., Research Division

Presentation

Operator

Advertisement

Good afternoon, and thank you for joining Zevra’s Fourth Quarter and Full Year 2025 Financial Results and Corporate Update Conference Call. Today’s call is being recorded and will be available via the Investor Relations section of the company’s website later today. The host for today’s call is Nichol Ochsner, Zevra’s Vice President of Investor Relations and Corporate Communications.

Nichol Ochsner
Vice President of Investor Relations & Corporate Communications

Thank you, and welcome to those who are joining us. Today, we will provide an overview of our recent accomplishments, followed by a review of our fourth quarter and full year 2025 financial results. I encourage you to read the financial results news release, which was distributed this afternoon, and is available in the Investors section of our website.

Advertisement

Before we begin the call, please note that certain information shared today will include forward-looking statements. Actual results may differ materially from those stated or implied by forward-looking statements due to risks and uncertainties associated with Zevra’s business. Forward-looking statements are not promises or guarantees and are inherently subject to risks, uncertainties and other important factors that may lead to actual results differing materially from the projections made, and should be evaluated together with the Risk Factors section in

Advertisement
Continue Reading

Business

Goldman pitches hedge funds product to bet against corporate loans, source says

Published

on

Goldman pitches hedge funds product to bet against corporate loans, source says


Goldman pitches hedge funds product to bet against corporate loans, source says

Continue Reading

Business

STMicroelectronics N.V. (STM) Shareholder/Analyst Call – Slideshow

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

STMicroelectronics N.V. (STM) Shareholder/Analyst Call – Slideshow

Continue Reading

Business

Trump says he discussed Ukraine and Iran conflicts with Putin

Published

on

Trump says he discussed Ukraine and Iran conflicts with Putin


Trump says he discussed Ukraine and Iran conflicts with Putin

Continue Reading

Business

Form 4 The Trade Desk For: 9 March

Published

on


Form 4 The Trade Desk For: 9 March

Continue Reading

Business

National Bureau of Economic Research cuts ties with Larry Summers, WSJ reports

Published

on

National Bureau of Economic Research cuts ties with Larry Summers, WSJ reports


National Bureau of Economic Research cuts ties with Larry Summers, WSJ reports

Continue Reading

Business

Repay Holdings Corporation (RPAY) Q4 2025 Earnings Call Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Operator

Good afternoon, I’d like to welcome everyone to Repay’s Fourth Quarter 2025 Earnings Conference Call. This call is being recorded today, March 9, 2026.

I’d like to turn the session over to Stewart Grisante, Head of Investor Relations at Repay. Stewart, you may begin.

Advertisement

Stewart Grisante
Head of Investor Relations

Thank you. Good afternoon, and welcome to Repay’s Fourth Quarter 2025 Earnings Conference Call. With us today are John Morris, Co-Founder and Chief Executive Officer; and Robert Houser, Chief Financial Officer.

During this call, we will be making forward-looking statements about our beliefs and estimates regarding future events and results. Those forward-looking statements are subject to risks and uncertainties, including those set forth in the SEC filings related to today’s results and in our most recent Form 10-K. Actual results may differ materially from any forward-looking statements that we make today.

Forward-looking statements speak only as of today, and we do not assume any obligation or intend to update them except as required by law. In an effort to provide additional information to investors, today’s discussion will also reference certain non-GAAP financial measures. Reconciliations and other explanations of those non-GAAP financial measures can be found in today’s press release and in the earnings supplement, each of which are available on the company’s IR site.

Advertisement

With that, I will now turn the call over to John.

Continue Reading

Business

Wolfe Research reiterates Vertex stock rating on IgAN trial data

Published

on


Wolfe Research reiterates Vertex stock rating on IgAN trial data

Continue Reading

Trending

Copyright © 2025